Monitoring Adverse Effects of Antipsychotics and Antidepressants: A Population Based Study
Satya Sree Rallabandi1, Sai Samanth Makula1, Vasudeva Murthy Sindgi2, Bandari Jagadeesh Babu2, Usha Sree Puneem1★★ Corresponding author
- 1Department of Pharmacy Practice, Jayamukhi College of Pharmacy (Affiliated to Kakatiya) University, Warangal, Telangana, INDIA.
- 2Department of Pharmacology, Jayamukhi College of Pharmacy (Affiliated to Kakatiya) University, Warangal, Telangana, INDIA.
CORRESPONDENCE
Usha Sree Puneem
Department of Pharmacy Practice, Jayamukhi College of Pharmacy (Affiliated to Kakatiya) University, Warangal, Telangana, INDIA.
Volume 14, Issue 3 · pp. 191–197 · PUBLISHED · DOI: 10.5530/ijopp.14.3.38
ABSTRACT
Aim:To monitor the nature and incidences adverse effects of both antipsychotics and antidepressants medicines in the psychiatry outpatient department.Objectives:Reporting the incidences of adverse effects and to establish the frequency of a specific class of drug. Identifying the system affected and the assessment of the management of the adverse effects by the physician. For the study, we have adopted Global Assessment Scale (GAS), Simpson-Angus Extra pyramidal Side Effects Scale (SAS) and The Antidepressant Side-Effect Checklist (ASEC). Materials and Methods:A prospective cohort study carried out in the psychiatry out-patient department. All the patients attending psychiatry outpatient department enrolled based on the pre-specified inclusion criteria and monitored for adverse effects. Causality also assessed by WHO-UMC causality assessment system and Naranjo Causality Assessment. Results:The incidence rate of adverse effects (46.07%) and 560 adverse effects documented. Weight gain (n=29, 9.2%) followed by drowsiness (n=27, 4.82%) are most commonly reported adverse effects. Atypical antipsychotics (n=279, 49.82%) were the most common class of psychotropic drugs implicated in adverse effects. Escitalopram (n=93, 37.80%) followed by olanzapine (n=53, 21.54%) associated with a maximum number of adverse effects. Central nervous system (n=225, 40.17%) was the most affected organ system followed by gastrointestinal system (n=130, 23.21%). Conclusion: Study revealed moderate incidences of adverse effects in patients attending the psychiatry outpatient department. Majority of the adverse effects reported during the study were mild in nature and not preventable. The role of a clinical pharmacist clearly elucidated regular intensive monitoring of adverse effects may improve the quality of patients’ care, reduction in the treatment cost and augmentation of the medication adherence among patients.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Rallabandi, S. S., Makula, S. S., Sindgi, V. M., Babu, B. J., & Puneem, U. S. (). Monitoring Adverse Effects of Antipsychotics and Antidepressants: A Population Based Study. Indian Journal of Pharmacy Practice, 14(3), 191–197. https://doi.org/10.5530/ijopp.14.3.38
